Discussing the need for evidence-based drug policy
Science for Democracy co-founder and former Italian Senator Marco Perduca tells MCN about the need for evidence-based drug policy.
International platform Science for Democracy (SfD)...
ICANNA: cannabis in Slovenia
MCN speaks to the International Institute for Cannabinoids about cannabis education, policy and prohibition in Slovenia.
The International Institute for Cannabinoids (ICANNA) is a non-profit...
The LeafCann Group in 2020
Australia’s LeafCann Group is highly ambitious and dedicated to providing affordable, high quality products.
LeafCann’s mission is to supply the most effective and affordable precision...
Calls for urgent intervention to fund medical cannabis for Billy Caldwell
Charlotte Caldwell, the County Tyrone based mother who successfully campaigned to legalise medicinal cannabis in 2018, has called for urgent intervention to aid her...
Anspec: leading the way in Australia’s medicinal cannabis sector
Anspec, the largest distributor of medicinal cannabis in Australia, is committed to ongoing development and innovation within the sector.
Australian company Anspec has been in...
Wholesale Dealer’s Licence for LeafCann approved
LeafCann Manufacturing Pty Ltd (LeafCann), a subsidiary of LeafCann Group Pty Ltd, has received approval from the South Australian government for a Wholesale Dealer’s...
FDA given CBD regulation recommendations by NlHC
The National Industrial Hemp Council (NIHC) has recently given recommendations to the Food and Drug Administration (FDA) on CBD regulation.
The NIHC, which provides high-quality...
US cannabis testing market worth more than $1.2bn by 2026
New analysis from Global Market Insights, Inc., shows the US cannabis testing market will be worth $1.2bn by 2026.
The Global Market Insights report shows...
Clinical trial shows potential of cannabis to lessen sickle cell disease pain
In a first of its kind clinical trial using gold-standard methods, cannabis has been shown to mitigate the pain of sickle cell disease.
People who...
CBD blockchain tracing: new levels of transparency and accountability
The Cannabinoid Association of the Netherlands has launched a free to use blockchain-based search tool.
In a bid to drive higher levels of transparency and...
Successful initial results using cannabis terpenes to treat COVID-19
A study to test the efficacy of a unique cannabis terpene formulation for the treatment of viral infections, including COVID-19, has shown early promising...
Professor Mike Barnes outlines opportunity in the UK’s CBD market
The UK's CBD market has flourished despite the impact of COVID-19.
The rest of the world has steamed ahead with the legalisation of medical and...
Cannabinoid therapies aim to address unmet medical needs
Oxford Cannabinoid Technologies (OCT) has appointed a new Chief Scientific Officer to help deliver cannabinoid therapies for unmet medical needs.
Dr Valentino Parravicini, PhD will...
Project Twenty21: Europe’s largest medical cannabis registry goes live
Drug Science’s Project Twenty21, Europe’s largest medical cannabis patient registry, has gone live today, registering its first patient for a medical cannabis prescription.
The Project...
Currency UK: assessing the impact of COVID-19 on the CBD sector
Currency UK Head of Sales Ben Kohler assesses the impact of COVID-19 on foreign exchange within the CBD sector.
With CBD still being a relatively...
Advocacy group launches Australian Medicinal Cannabis Course Online
The recent Senate recommendations to substantially increase medical cannabis education for health professionals are being implemented by a leading advocacy group with the launch...
Introducing PLEA: the patient run medical cannabis advocacy group
Founded by a team of patient advocates with experience in the medical cannabis sector, PLEA has been set up to accelerate the integration of...
Formation of the Society of Cannabis Clinicians UK Chapter
The Society of Cannabis Clinicians (SCC) is partnering with the Sapphire Institute for Medical Cannabis Education to form the SCC UK Chapter.
SCC is a...
First medical cannabis patient to receive funding for one year
Sapphire Medical Foundation has announced its first patient has secured medicine funding for one year.
Two years following the rescheduling of cannabis-based medicinal products in...
Cannabidiol market to be worth more than $89bn by 2026
A report published by Global Market Insights, Inc., shows that the cannabidiol market size is expected to surpass $89.0bn in revenue by 2026.
The report...
